The group will present the first clinical data on its KRAS G12D-selective project RMC-9805.

An initial winner of the ASCO abstract reveal, Verastem drops a bombshell.

Novartis' Jakafi faces competition from GSK's momelotinib, while Astra looks over its shoulder at Merck in biliary tract cancer.